QCM
CNMD icon

Qsemble Capital Management’s CONMED CNMD Stock Holding History

Qsemble Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,245
Closed -$294K – 406
2024
Q2 		$294K Buy
+4,245
New +$310K 0.06% 351

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Qsemble Capital Management's CNMD Position: Q3 2024 in Review

Qsemble Capital Management sold out of CONMED (CNMD) in Q3 2024, closing a stake of 4,245 shares — an estimated $294K sold.

Qsemble Capital Management first reported a position in CNMD in Q2 2024 and held it in 1 quarter. The position peaked at $294K in Q2 2024. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Qsemble Capital Management reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
  • Qsemble Capital Management sold 4,245 CONMED shares in Q3 2024, an estimated $294K.
  • Qsemble Capital Management first reported a position in CONMED in Q2 2024 and held it in 1 quarter.
  • Qsemble Capital Management's CONMED position peaked at $294K in Q2 2024.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Qsemble Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.